Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,726 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07588347 | Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence | not yet recruiting | N/A | 72 | Feifei HuangOTHER | 0 | May 19, 2026 | clinicaltrials |
| NCT07594834 | Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies | not yet recruiting | N/A | 20 | Haibo ShaoOTHER | 0 | May 19, 2026 | clinicaltrials |
| NCT07596524 | Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy | not yet recruiting | — | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07596732 | Statewide Unified Network for Remote Intervention of Strength and Exercise(SUNRISE) | not yet recruiting | N/A | 120 | AdventHealth Translational Research InstituteOTHER | 0 | May 19, 2026 | clinicaltrials |
| NCT07014878 | A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors | not yet recruiting | Phase 1 | 18 | Beijing DCTY Biotech Co.,Ltd.OTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593872 | XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer(XR-NeckLND) | not yet recruiting | N/A | 10 | National Taiwan University HospitalOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07589101 | 5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07590440 | Indian Lung Screening Trial(ILST) | not yet recruiting | N/A | 1,716 | All India Institute of Medical SciencesOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07376382 | A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLC(SYNSTAR-02) | not yet recruiting | Phase 3 | 680 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 0 | May 13, 2026 | clinicaltrials |
| NCT07583316 | A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors | not yet recruiting | Phase 1 | 192 | Corregene Biotechnology Co., LtdINDUSTRY | 1 | May 13, 2026 | clinicaltrials |
| NCT07583771 | A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma | not yet recruiting | Phase 1 | 186 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | May 13, 2026 | clinicaltrials |
| NCT07574684 | Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLC(ALA /NSCLC) | not yet recruiting | Phase 2 | 60 | Ain Shams UniversityOTHER | 0 | May 8, 2026 | clinicaltrials |
| NCT07573696 | Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy | not yet recruiting | Phase 2 | 50 | Wen-zhao ZHONGOTHER | 0 | May 7, 2026 | clinicaltrials |
| NCT07573748 | Apple Vision Pro-Assisted Vascular Identification in Lung Surgery(AVP-Lung) | not yet recruiting | N/A | 20 | The Second People's Hospital of Huai'anOTHER | 0 | May 7, 2026 | clinicaltrials |
| NCT07574255 | 3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application | not yet recruiting | — | 300 | National Taiwan University HospitalOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT07247786 | Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)(MIGRANT) | not yet recruiting | Phase 2 | 68 | Fundación GECPOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07258147 | Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases | not yet recruiting | Phase 2 | 30 | Sichuan UniversityOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07567313 | Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy | not yet recruiting | Phase 4 | 166 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | May 5, 2026 | clinicaltrials |
| NCT07567326 | Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC | not yet recruiting | Phase 2 | 78 | Peking University Cancer Hospital & InstituteOTHER | 0 | May 5, 2026 | clinicaltrials |
| NCT07560358 | Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer | not yet recruiting | Phase 3 | 204 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07561983 | Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC(BEACON-Lung) | not yet recruiting | Phase 2 | 39 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT07558200 | Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors | not yet recruiting | Phase 1 | 138 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07379398 | Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer | not yet recruiting | Phase 2 | 28 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07549061 | Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC | not yet recruiting | Phase 2 | 19 | Shanghai Chest HospitalOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07554859 | GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer | not yet recruiting | Phase 2 | 90 | Genfleet Therapeutics (Shanghai) Inc.INDUSTRY | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07551635 | SMARCA4/2 Inhibitor for POU2F3-Positive SCLC | not yet recruiting | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07550049 | Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology(COMETH) | not yet recruiting | — | 110 | University of Kansas Medical CenterOTHER | 0 | Apr 24, 2026 | clinicaltrials |
| NCT07550842 | A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | not yet recruiting | Phase 1 | 33 | Shanghai Best-Link Bioscience, LLCINDUSTRY | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07550920 | Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2) | not yet recruiting | Phase 2 | 18 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Apr 24, 2026 | clinicaltrials |
| NCT07551414 | Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI | not yet recruiting | Phase 2 | 38 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07547332 | Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC | not yet recruiting | Phase 2 | 84 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 0 | Apr 23, 2026 | clinicaltrials |
| NCT07548788 | A Lay Navigation Intervention for Patients With Lung Cancer | not yet recruiting | N/A | 50 | University Health Network, TorontoOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT07545213 | Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis | not yet recruiting | Phase 2 | 27 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07542704 | A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies | not yet recruiting | Phase 1 | 48 | Kumquat Biosciences Inc.INDUSTRY | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07538258 | Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer(Aurora004) | not yet recruiting | Phase 2 | 27 | Yayi HeOTHER | 0 | Apr 20, 2026 | clinicaltrials |
| NCT07538271 | A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer(Aurora 005) | not yet recruiting | Phase 2 | 33 | Yayi HeOTHER | 0 | Apr 20, 2026 | clinicaltrials |
| NCT07538973 | A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function | not yet recruiting | Phase 1 | 24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07539701 | An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy(CELSIO) | not yet recruiting | N/A | 30 | Institut universitaire de cardiologie et de pneumologie de Québec, University LavalOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07470476 | Pathophysiological Mechanisms Involved in the Pronostic and Evolution of Non-Small Cell Lung Cancer (NSCLC) at All Stages of the Disease(EMA) | not yet recruiting | — | 150 | University Hospital, BordeauxOTHER | 0 | Apr 17, 2026 | clinicaltrials |
| NCT07536178 | Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada(LoF) | not yet recruiting | N/A | 24 | University of British ColumbiaOTHER | 0 | Apr 17, 2026 | clinicaltrials |
| NCT07530744 | Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection(Cronos) | not yet recruiting | N/A | 20 | Elisabethinen HospitalOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07520799 | The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy | not yet recruiting | N/A | 60 | Firat UniversityOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07501169 | Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)(STAR-01) | not yet recruiting | Phase 2 | 33 | Sichuan UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07521618 | One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation(One-stop) | not yet recruiting | N/A | 30 | Guangzhou Medical UniversityOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07524803 | Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)(LUCAS-LATAM) | not yet recruiting | — | 2,000 | Latin American Consortium for the Lung Cancer ResearchOTHER | 2 | Apr 13, 2026 | clinicaltrials |
| NCT06816979 | Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer | not yet recruiting | N/A | 40 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07506889 | Simplified Exercise-based Risk Assessment in Lung Cancer(EXHALE-CO2) | not yet recruiting | — | 500 | Linkoeping UniversityOTHER_GOV | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07517640 | Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial | not yet recruiting | Phase 2 | 45 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07516015 | Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC | not yet recruiting | — | 1,000 | Nanjing Tianyinshan HospitalOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT06706219 | Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC | not yet recruiting | Phase 2 | 50 | Hunan Province Tumor HospitalOTHER | 1 | Apr 3, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 19, 2026source: clinicaltrials